Literature DB >> 24558655

Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization.

T T de Melo, I C de Sena, N Araujo, C T Fonseca.   

Abstract

The Schistosoma mansoni schistosomula tegument (Smteg) plays an important role in triggering the host immune response and mice immunization with Smteg formulated with Freunds adjuvant or alum + CpG induce partial protection against S. mansoni infection associated with an increased antibody production. In this study, we investigated the role of these antibodies in parasite killing both in vitro and in vivo. We demonstrated that these antibodies were able to bind to the surface of S. mansoni recently transformed schistosomula and that these antibodies significantly increase the percentage of schistosomula killed in vitro by complement activation. Passive transference of immune sera decreased the parasite burden and the number of eggs trapped in the organs of mice that received sera containing anti-Smteg antibodies. These results demonstrate that antibodies specific to surface tegumental antigens are involved in parasite elimination in mice immunized with Smteg.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24558655     DOI: 10.1111/pim.12091

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  12 in total

1.  Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.

Authors:  Adebayo J Molehin; Souad R Sennoune; Weidong Zhang; Juan U Rojo; Arif J Siddiqui; Karlie A Herrera; Laura Johnson; Justin Sudduth; Jordan May; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2017-10-12       Impact factor: 2.289

2.  Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection.

Authors:  Clarice Carvalho Alves; Neusa Araujo; Viviane Cristina Fernandes dos Santos; Flávia Bubula Couto; Natan R G Assis; Suellen B Morais; Sérgio Costa Oliveira; Cristina Toscano Fonseca
Journal:  PLoS Negl Trop Dis       Date:  2015-02-27

Review 3.  Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?

Authors:  Cristina Toscano Fonseca; Sergio Costa Oliveira; Clarice Carvalho Alves
Journal:  Front Immunol       Date:  2015-03-09       Impact factor: 7.561

4.  Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.

Authors:  Marwa H El-Faham; Maha M Eissa; Joseph E Igetei; Eglal I Amer; Susan Liddell; Mervat Z El-Azzouni; Michael J Doenhoff
Journal:  PLoS Negl Trop Dis       Date:  2017-08-25

5.  Specific anti-glycan antibodies are sustained during and after parasite clearance in Schistosoma japonicum-infected rhesus macaques.

Authors:  Y Y Michelle Yang; Xiao Hong Li; Katarzyna Brzezicka; Niels-Christian Reichardt; R Alan Wilson; Angela van Diepen; Cornelis H Hokke
Journal:  PLoS Negl Trop Dis       Date:  2017-02-02

6.  Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.

Authors:  Belén Vicente; Julio López-Abán; Jose Rojas-Caraballo; Esther del Olmo; Pedro Fernández-Soto; Antonio Muro
Journal:  Parasit Vectors       Date:  2016-04-18       Impact factor: 3.876

7.  A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis.

Authors:  Alessandra Ricciardi; Kittipos Visitsunthorn; John P Dalton; Momar Ndao
Journal:  BMC Infect Dis       Date:  2016-03-05       Impact factor: 3.090

8.  Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice.

Authors:  Suellen B Morais; Barbara C Figueiredo; Natan R G Assis; Jane Homan; Fábio S Mambelli; Rodrigo M Bicalho; Cláudia Souza; Vicente P Martins; Carina S Pinheiro; Sergio C Oliveira
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

9.  A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against Schistosoma mansoni Reinfection in Mice.

Authors:  Clarice Carvalho Alves; Neusa Araujo; Wilma Patrícia de Oliveira Santos Bernardes; Mariana Moreira Mendes; Sergio Costa Oliveira; Cristina Toscano Fonseca
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

10.  Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model.

Authors:  Adam S Hassan; Nicholas H Zelt; Dilhan J Perera; Momar Ndao; Brian J Ward
Journal:  PLoS Negl Trop Dis       Date:  2019-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.